The US Food and Drug Administration on Monday granted Emergency Use Authorization to two lab-developed real-time RT-PCR tests for SARS-CoV-2, the virus that causes coronavirus disease COVID-19. The authorized tests are performed at Knoxvill... Read More >

Illumina reported after the close of the market on Tuesday preliminary first quarter revenues of approximately $858 million. The firm also withdrew its full-year revenue guidance due to disruption from the COVID-19 pandemic. The firms reven... Read More >

Fluidigm said after the close of the market on Tuesday that it expects Q1 revenues of approximately $27.6 million. Expected revenues would represent an 8 percent year-over-year decline from $30.1 million a year ago and fall short of analyst... Read More >

The National Institutes of Health have started recruiting for a new study that aims to determine how many adults in the US who have not had a confirmed infection with SARS-CoV-2 carry antibodies to the virus, indicating that they were previ... Read More >

From a purple dot in Wuhan, China, lines start to emerge, reaching the UK, Thailand, and Australia. New colors appear, representing genetic changes that occur in the SARS-CoV-2 coronavirus as it moves, infects large groups of people, and mu... Read More >

NEW YORK LexaGene, which has developed a pathogen detection platform for the veterinary and food safety sectors, is now pivoting to clinical diagnostics by modifying its LX Analyzer platform for viruses, including SARS-CoV-2, the virus behi... Read More >

NEW YORK A team led by researchers at St. Jude Childrens Research Hospital, the European Molecular Biology Laboratory, and the German Cancer Research Center have identified a novel inherited gene that predisposes children to developing the... Read More >

Nefertiti Brown, MDs life is on pause right now. The 39-year-old physician is quarantined in her home, awaiting results from a COVID-19 test she took nearly two weeks ago. Dr. Brown, a graduate of the University of Pittsburgh School of Medi... Read More >

Abbotts new ID NOW COVID-19 test, which earned emergency use authorization (EUA) from FDA last week, was highlighted during President Donald Trumps COVID-19 taskforce press briefing on March 30. FDA Commissioner Stephen Hahn spoke about the... Read More >

A smallSan Diego, CA-based company has joined the ongoing battle against the new coronavirus. Cue Medical secured a U.S. government contract to deliver itsportablepoint-of-care diagnostic test for the detection of SARS-Cov-2, the virus that... Read More >